At first glance IHHT looks like a brand-new idea: you rest, breathe through a light mask and alternate between low-oxygen and oxygen-rich air. In reality it sits on a line of research that is more than half a century old.
From altitude medicine to interval technique
The starting point is an old observation: people who spend time in thin air change their breathing, blood values and metabolism. From the 1960s onwards researchers tried to use that adaptation deliberately — first in sports medicine, then in occupational, diving and space medicine, where people had to be prepared for unusual oxygen conditions on a schedule.
One of the physicians who carried that line towards a workable method is Dr Arkadi Prokopov. He came from research into adaptation to low oxygen in divers and cosmonauts, and later worked in Germany on dosing the stimulus so that it can be applied at rest and steered individually. Several patents on interval control grew out of that work.
- Altitude medicine: adaptation to thin air as the observed principle.
- Occupational medicine: controlled preparation for unusual oxygen levels.
- Engineering: devices that regulate air mixtures finely and safely.
- Today: control through oxygen saturation and pulse in real time.
Why the alternation mattered
The real step was moving from plain hypoxia to a sequence of hypoxia and hyperoxia. The oxygen-rich phase shortens recovery between intervals and allows shorter, more clearly defined stimuli. Reviews summarise the principle as „hypoxic conditioning" and describe how varied the protocols still are [2].
It is not the altitude that defines the method, but the dose: short, repeated and monitored while it happens.
What has become of it today
A 2022 systematic review collected human studies on intermittent hypoxia-hyperoxia [1]. The picture is typical of a young field: there are signals around performance and resilience, while duration, target groups and outcome measures differ widely. Smaller controlled studies, for instance on cognitive performance, are research findings rather than proof of benefit in an individual case [3].
- Established: how cells sense oxygen.
- Under study: what individual protocols do for everyday life and performance.
- Open: the optimal dose and who responds most.
What this means for you
If you want to try IHHT, look less at promises and more at origin and control: certified technology, an honest first conversation and a series over several weeks rather than a single appointment. You can read more about the person behind this development on the page about Arkadi Prokopov.